Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P Futures
5,913.50
+7.50(+0.13%)
Dow Futures
43,574.00
+56.00(+0.13%)
Nasdaq Futures
20,517.75
+34.25(+0.17%)
Russell 2000 Futures
2,296.70
+5.50(+0.24%)
Crude Oil
69.41
+0.19(+0.27%)
Gold
2,742.20
+12.20(+0.45%)

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

59.09

+0.17

(+0.29%)

At close: 04:00PM EDT

59.95

+0.86

(+1.46%)

After hours:

05:18PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	5.32B
Enterprise Value	4.51B
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	2.94k
Price/Book (mrq)	6.40
Enterprise Value/Revenue	3.26k
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	0.64
52-Week Change ³	109.09%
S&P500 52-Week Change ³	39.07%
52 Week High ³	59.80
52 Week Low ³	25.75
50-Day Moving Average ³	52.62
200-Day Moving Average ³	46.43

Share Statistics

Avg Vol (3 month) ³	676.35k
Avg Vol (10 day) ³	1.15M
Shares Outstanding ⁵	90.04M
Implied Shares Outstanding ⁶	90.04M
Float ⁸	78.9M
% Held by Insiders ¹	1.87%
% Held by Institutions ¹	95.93%
Shares Short (Sep 30, 2024) ⁴	6.78M
Short Ratio (Sep 30, 2024) ⁴	10.65
Short % of Float (Sep 30, 2024) ⁴	8.65%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	8.47%
Shares Short (prior month Aug 30, 2024) ⁴	6.22M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-20,747.62%

Management Effectiveness

Return on Assets (ttm)	-28.27%
Return on Equity (ttm)	-47.66%

Income Statement

Revenue (ttm)	1.39M
Revenue Per Share (ttm)	0.02
Quarterly Revenue Growth (yoy)	-59.60%
Gross Profit (ttm)	N/A
EBITDA	-276.18M
Net Income Avi to Common (ttm)	-258.54M
Diluted EPS (ttm)	-3.76
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	862.95M
Total Cash Per Share (mrq)	10.78
Total Debt (mrq)	53.32M
Total Debt/Equity (mrq)	6.42%
Current Ratio (mrq)	16.09
Book Value Per Share (mrq)	10.47

Cash Flow Statement

Operating Cash Flow (ttm)	-178.33M
Levered Free Cash Flow (ttm)	-99.73M